Medical/Pharmaceuticals

Medidata and the University of Sydney's NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia

Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and raising the standard of clinical trials SINGAPORE, July 10, 2025 /PRNewswire/ -- Medidata , a Dassault Systèmes br...

2025-07-10 08:00 2368

LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico's Life Sciences Market

NORWALK, Conn., July 9, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, is pleased to announce the expansion of its distribution partnership with Clariant, a global leader in the development and manufacturing of specialty c...

2025-07-09 23:00 2180

NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports

NEW YORK, July 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content advisory: Pre-Market update + Trump announces 50% le...

2025-07-09 20:55 3274

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

SHANGHAI, NANJING, China and SAN FRANCISCO, July 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced thatits self-developed an...

2025-07-09 20:18 2300

Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets

WALTHAM, Mass., July 9, 2025 /PRNewswire/ -- Sironax, a clinical-stage biotech company dedicated to the discovery and development of transformational therapies for age-related diseases, today announced a strategic agreement with Novartis under which Sironax will grant Novartis an exclusive option...

2025-07-09 20:00 2399

Gozellix Receives Permanent HCPCS Code

MELBOURNE, Australia, July 9, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that its next-generation PSMA[1] PET[2] imaging agent, Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), has been granted a permanent Hea...

2025-07-09 12:41 3450

Watson-Marlow Fluid Technology Solutions focuses on BioClamp's sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025

TOKYO, July 9, 2025 /PRNewswire/ -- Visitors to the Watson-Marlow Fluid Technology Solutions booth W15-2 at INTERPHEX Tokyo 2025 (July 9-11 at Tokyo Big Sight, Japan) can learn more about the new WMArchitect Interchangeable Parts service as well as how recently advanced manufacturing of BioClamp ...

2025-07-09 11:30 2183

BiomeNrich™ PRO G814 & PRO G952: Globally Recognized Bifidobacterium Solutions Now Targeting Southeast Asia's Wellness Market

SEOUL, South Korea, July 9, 2025 /PRNewswire/ -- As Southeast Asia's health and wellness market rapidly evolves, consumer expectations are shifting toward multifunctional solutions that go beyond basic digestion. Gut health is now understood as the foundation for immune support, skin clarity, men...

2025-07-09 07:00 2946

Technimark Unveils New Brand Identity: "We Make What Makes Life Better"

ASHEBORO, N.C., July 9, 2025 /PRNewswire/ -- Technimark, a world leader in manufacturing for healthcare, consumer packaging, and industrial sectors, today launched a new brand identity to reflect the company's transformation into a global manufacturing leader, known for its reliability and excell...

2025-07-09 00:00 2366

Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science

A recognized pioneer in metabolomics, Metabolon is the most experienced and trusted metabolomics partner in the life sciences industry MORRISVILLE, N.C., July 8, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science ...

2025-07-08 21:00 1813

GLOBAL NUTRACEUTICALS CAMPAIGN TO RAISE FUNDS FOR RESCUE SHELTER FOR CHILD SEXUAL ABUSE SURVIVORS

#HopeNeedsAHome Cypress Minerals and Cepham Inc lead Fundraising Efforts Because Hope Needs A Home - Deadline Looms As Mothers, Aged 11-17, Hope For Sanctuary they can call Home $140,000 USD needed by August 15 to Secure Home for young Mothers MADERA, Calif., July 8, 2025 /PRNewswire/ -- Tw...

2025-07-08 20:00 1616

3D-PRINTED CUSTOM INSOLES: ADVANCING DIABETIC FOOT CARE AT SENGKANG GENERAL HOSPITAL

SINGAPORE, July 8, 2025 /PRNewswire/ -- Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore General Hospital's (SGH) 3D printing centre. Traditional p...

2025-07-08 18:47 2150

Zuellig Pharma Launches "Obesity is a Disease" Seminar as Part of "Reduce Size, Reduce Disease" Campaign

The campaign aims to enhance the understanding of obesity as a chronic disease and solutions to help manage the disease among Thais and healthcare providers. BANGKOK, July 8, 2025 /PRNewswire/ -- Zuellig Pharma, a leading healthcare solutions provider inAsia, is organizing the "Obesity is a Disea...

2025-07-08 16:29 2723

SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V

SINGAPORE, July 8, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the Investigation...

2025-07-08 10:02 3539

Better by MTA Highlights Platinum Members Elevating Global Healthcare Standards

PALM BEACH GARDENS, Fla., July 8, 2025 /PRNewswire/ -- Better by MTA, the leading medical tourism platform, is proud to spotlight its distinguished Platinum Members—organizations that exemplify leadership, excellence, and innovation in the global medical travel industry. These members have played ...

2025-07-08 02:26 1903

Sirtex Medical's SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma

Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, Mass., July 7, 2025 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of intervent...

2025-07-07 21:00 2489

DoH, USCF and IGI Explore Establishing the World's first-of-their kind Centres for Genome Surgery

On the sidelines of a high-level U.S. visit ABU DHABI, UAE, July 4, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a landmark partnership with the University of California, San Francisco (UCSF) and the Innovati...

2025-07-04 22:43 3220

Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai

SHANGHAI, July 4, 2025 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the "2025 Everest Medicines mRNA Platform R&D Day" in Shanghai. The e...

2025-07-04 16:58 3283

Kexing Biopharm Makes Its Debut at CPHI 2025, Followed by the 2025 International Pharmaceutical Cooperation High-End Forum, One of the Kexing Biopharm's Series of Globalization Activities in Shanghai

SHENZHEN, China, July 4, 2025 /PRNewswire/ -- Recently, Kexing Biopharm made a remarkable appearance at CPHI & PMEC China 2025 and successfully organized the 2025 International Pharmaceutical Cooperation High-End Forum, one of the Kexing Biopharm's series of globalization activities in Shanghai. ...

2025-07-04 16:26 4006

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

* Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China * Brii Biosciences retains ex-Greater China rights to address the global antimicrobial resistance threats and continues investment in other priority pipeline assets DURHAM, N.C. and BEIJING, J...

2025-07-04 08:30 3568
1 ... 42434445464748 ... 394

Week's Top Stories